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Development/Plasticity/Repair
Dopamine Receptor Activation Modulates GABA Neuron
Migration from the Basal Forebrain to the Cerebral Cortex
James E. Crandall,1Deirdre M. McCarthy,2 Kiyomi Y. Araki,2 John R. Sims,2,3 Jia-Qian Ren,3 and Pradeep G. Bhide2
1Eunice Kennedy Shriver Center for Mental Retardation, Physiology, University of Massachusetts Medical School, Waltham, Massachusetts 02452, and
Departments of 2Neurology and 3Radiology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02129
GABA neurons of the cerebral cortex and other telencephalic structures are produced in the basal forebrain and migrate to their final
destinations during the embryonic period. The embryonic basal forebrain is enriched in dopamine and its receptors, creating a favorable
environment for dopamine to influence GABA neuron migration. However, whether dopamine receptor activation can influence GABA
neuron migration is not known. We show that dopamine D1 receptor activation promotes and D2 receptor activation decreases GABA
neuron migration from the medial and caudal ganglionic eminences to the cerebral cortex in slice preparations of embryonic mouse
forebrain. Slice preparations fromD1 or D2 receptor knock-outmouse embryos confirm the findings. In addition, D1 receptor electropo-
ration into cells of the basal forebrain andpharmacological activation of the receptor promotemigration of the electroporated cells to the
cerebral cortex. Analysis of GABA neuron numbers in the cerebral wall of the dopamine receptor knock-out mouse embryos further
confirmed the effects of dopamine receptor activation on GABA neuron migration. Finally, dopamine receptor activation mobilizes
striatal neuronal cytoskeleton in a manner consistent with the effects on neuronal migration. These data show that impairing the
physiological balance betweenD1 andD2 receptors can alter GABAneuronmigration from the basal forebrain to the cerebral cortex. The
intimate relationship between dopamine and GABA neuron development revealed here may offer novel insights into developmental
disorders such as schizophrenia, attention deficit or autism, and fetal cocaine exposure, all of which are associated with dopamine and
GABA imbalance.
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Introduction
GABA neurons constitute 20–30% of all neurons in the cerebral
cortex and perform critical roles in modulating cortical func-
tional output (Cherubini andConti, 2001; Krimer andGoldman-
Rakic, 2001). During development, GABA neurons modulate
neocortical neuroepithelial cell proliferation, neuronal migra-
tion, and circuit formation (Owens andKriegstein, 2002; Ben-Ari
et al., 2004). Abnormalities in GABA neuron function occur in a
variety of developmental disorders, including epilepsy, schizo-
phrenia, anxiety, and autism (Benes, 2000; Treiman, 2001; Levitt
et al., 2004). Cortical GABA neurons are produced in the medial
and caudal ganglionic eminences of the basal forebrain and mi-
grate to the cerebral wall during the embryonic period (Anderson
et al., 1997; Lavdas et al., 1999;Wichterle et al., 2001). A variety of
homeobox transcription factors, growth factors and their recep-
tors, or chemoattractant/repulsive molecules regulate cortical
GABA neuron migration and development (Rubenstein and Ra-
kic, 1999; Zhu et al., 1999; Powell et al., 2001; Polleux et al., 2002;
Alifragis et al., 2004; Flames et al., 2004). However, a direct link
between these factors and developmental disorders involving
GABA neuron dysfunction is not yet established, suggesting that
some other upstream etiological factor(s) may contribute to
GABA neuron dysfunction under those conditions.
A hallmark of developmental disorders such as schizophrenia,
epilepsy, or autism is the involvement ofmultiple neurotransmit-
ter systems, especially dopamine and GABA (Benes, 2000; Rob-
inson et al., 2001; Treiman, 2001; Casanova et al., 2003; Levitt et
al., 2004). Prenatal cocaine exposure also impairs dopamine
(Wang et al., 1995; Friedman et al., 1996; Stanwood and Levitt,
2007) and GABA systems (Crandall et al., 2004). However,
whether dopamine can influence GABA neuron development is
not known. The embryonic basal forebrain, which is the source of
cerebral cortical GABA neurons, is enriched in dopamine and its
receptors (Ohtani et al., 2003), offering a favorable environment
for dopamine and GABA interactions to occur during brain
development.
We show that dopamine can modulate GABA neuron migra-
tion from the basal forebrain to the cerebral cortex in embryonic
mice and that altering the physiological balance between D1 and
D2 receptor activation can impair GABA neuron migration.
These data suggest that dopamine imbalancemay at least initially
contribute to impairment of GABA neuron development in dis-
orders such as schizophrenia or in prenatal cocaine exposure.
Furthermore, our data show that dopamine imbalance can im-
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pair GABA neuron development even in
regions such as the cerebral cortex that do
not express high levels of dopamine or do-
pamine receptors early in embryonic de-
velopment (Ohtani et al., 2003). Our data
offer novel insights into an intimate and
symbiotic relationship between dopamine
and GABA in the developing brain, which
may be pertinent for understanding the
pathophysiology of an entire class of neu-
rofunctional developmental disorders
characterized by imbalance in multiple
neurotransmitter systems.
Materials andMethods
Animals. Timed-pregnant CD1 mice were pur-
chased from Charles River Laboratories (Wil-
mington, MA). Colonies of dopamine D1 and
D2 receptor knock-out mice (purchased from
The Jackson Laboratory, Bar Harbor,ME) were
maintained in our institutional animal facility.
Female mice housed with a male for the previ-
ous 15–17 h were examined for the presence of
vaginal plugs at 9:00 A.M. Presence of the plug
was taken to indicate conception, and the day of
plug discovery was designated embryonic day 0
(E0). Genotyping of the dopamine receptor
knock-out mice was performed according to
protocols available from The Jackson
Laboratory.
Brain slice preparation and culture. Neuronal
migration from the basal forebrain to the cere-
bral wall was assayed in slice preparations of the
embryonic telencephalon as described previ-
ously (Crandall et al., 2004). Briefly, E15 mice
were removed one at a time from dams deeply
anesthetized by an intraperitoneal injection of a
mixture of ketamine (50 mg/kg) and xylazine
(10 mg/kg). Age of the embryos was confirmed
by crown-rump length (13–15mm) and other external features (Theiler,
1972; Kaufman, 1992). The embryos were decapitated; the brains were
removed and embedded in 8% agarose (type VII; Sigma, St. Louis. MO).
Coronal sections of the brain were cut at a thickness of 250 m on a
vibratome. The sections were cultured individually on membrane filters
in polycarbonate transwells (Costar, Corning, NY), placed in a six-well
cell culture plate. Neurobasal medium (Invitrogen, Carlsbad, CA) con-
taining 2% B-27 supplement, penicillin, streptomycin, and glutamine
was added beneath the filter into each well. The slices weremaintained in
culture for 2 d. The medium was replaced at the end of the first 24 h.
Addition of dopamine or dopaminergic drugs. Dopamine (1, 10, or 20
M; Sigma) plus ascorbic acid (0.01%; Sigma), ascorbic acid alone
(0.01%), dopamine D1 like receptor agonist SKF 81297 (6-chloro-
2,3,4,5-tetrahydro-1-phenyl-1H-3-benzazepine hydrobromide) (1 or 10
M; Sigma), or D2 like receptor agonist quinpirole hydrochloride (10 or
20 M; Sigma) was added to the medium 2–3 h after plating. Ascorbic
acid was used as an antioxidant to retard oxidation of dopamine in the
culturemedium (Ohtani et al., 2003; Popolo et al., 2004). In other exper-
iments, dopamine D1 like receptor antagonist SCH 23390 [R()-7-
chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benza-
zepine hydrochloride] (10 M; Sigma) or D2 like receptor antagonist
eticlopride (20 M) was added to the culture medium 2–3 h after plating
the cells, and, 2 h later, dopamine plus ascorbic acid or ascorbic acid
alone were added.
DiI labeling of cells in the slice preparations.Glass shards coatedwithDiI
(Invitrogen) were prepared (Crandall et al., 2004) and inserted into the
basal forebrain with the aid of a stereomicroscope immediately after
plating each slice. We classified the slices into rostral or caudal groups
based on anatomical landmarks (Fig. 1). A principal criterion was that
the rostral slices contained both the lateral and medial ganglionic emi-
nences (Fig. 1A), whereas a single, caudal ganglionic eminence could be
identified in the caudal slices (Fig. 1B). Additionally, the rostral slices
contained striatal and septal primordia (Fig. 1A), whereas rostral tha-
lamic structures were visible in the caudal slices (Fig. 1B). Although the
majority of the cells migrating to the cerebral wall originate in themedial
and caudal ganglionic eminences (Wichterle et al., 1999, 2001; Parna-
velas, 2000; Nery et al., 2002), at E15 some cells derived from the lateral
ganglionic eminence also migrate to the cerebral wall (Anderson et al.,
2001). It is not possible to reliably label only the cells derived from the
lateral ganglionic eminence or the medial ganglionic eminence in the
rostral slices because the migratory paths of the cells overlap within
the basal forebrain. Therefore, in rostral slices, the DiI was inserted
200–400 m ventral to the pallidal-striatal angle (Fig. 1A) so as to
label cells originating in the lateral as well as medial ganglionic emi-
nences. In the caudal slices, the migrating cells originate in the caudal
ganglionic eminence, and the DiI crystals were inserted in the caudal
ganglionic eminence, 200–400 m ventral to the pallial-striatal angle in
these slices (Fig. 1B).
Analysis of cell migration.After 2 d in culture, the slices were fixed with
4% paraformaldehyde in 0.1 M phosphate buffer, pH 7.2, and viewed as
whole mounts in a fluorescence microscope fitted with tetramethylrho-
damine isothiocyanate filters (examples in Fig. 1C–E). The extent of the
DiI injection site was delimited for each slice as a solidly intense fluores-
cent area. The position of DiI-labeled neurons was recorded with respect
to the boundaries of the slice using an image analysis system (IPLab;
Scanalytics, Rockville, MD) interfaced to the microscope. A single inves-
tigator blinded to the identity of the experimental group performed the
Figure 1. Neuronalmigration assay using DiI labeling ofmigrating cells in forebrain slice preparations from E15mice. A andB
are bright-field images of representative rostral (A) and caudal (B) slices. DiI crystals (red clumps)were inserted approximately at
the border between the lateral andmedial ganglionic eminences (LGE andMGE, respectively) in rostral slices (A) and in the caudal
ganglionic eminence (CGE) in caudal slices (B). In the rostral slices, the DiI-labeled cells originate in both the lateral and medial
ganglionic eminences andmigrate inmultiple directions (red arrows), including toward the cerebralwall (CX). In the caudal slices,
the DiI-labeled cells originate in the caudal ganglionic eminence and also migrate in multiple directions (red arrows), including
toward the cerebral wall (CX).We counted the total number of DiI-labeled cells in the slices and calculated the percentage of cells
entering the cerebral cortex (as a percentage of the total number of DiI-labeled cells in the slice). C–E are examples of slice
preparations showing DiI-labeled cells (white arrows) that have migrated to the cerebral cortex (CX). The slices were exposed to
medium without any drugs (control; C), medium containing the D1 receptor agonist SKF 81297 (1 M; D), or the D2 receptor
agonist quinpirole (20 M; E) and maintained for 2 d in vitro. The DiI deposition site in the basal forebrain is visible (white
asterisks). S, Septum; TH, thalamus, LV, lateral ventricle.
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analyses. An overlay grid of rectangles (each 640  480 m), “grid
boxes,” was placed on the image of the slice to measure the overall extent
of neuronal migration. We calculated the percentage of DiI-labeled cells
that entered the cerebral wall as a percentage of the total number of
DiI-labeled cells in that slice. For this measurement, any DiI-labeled cell
found dorsal and lateral to the pallial-striatal angle was considered to
have reached the cortex.
Electroporation of D1 receptor constructs in slice preparations.Wild-type
mouse D1 receptor–enhanced green fluorescent protein (EGFP) (Araki
et al., 2006) was inserted downstream of the second CAG promoter of
pCAG–enhanced yellow fluorescent protein (EYFP)–CAG vector (Niwa
et al., 1991) (kind gift fromDr. T. Saito, KyotoUniversity, Kyoto, Japan).
TheD1 receptor–EGFP construct used here induces expression of a func-
tional D1 receptor as shown by agonist-induced upregulation of dopa-
mine and cAMP-regulated phosphoprotein-32 and cAMP synthesis
(Araki et al., 2006). However, the D1 receptor–EGFP construct did not
produce strong EGFP fluorescence in the transfected cells (Araki et al.,
2006). Therefore, in the present study, we used the pCAG–EYFP–CAG
vector to enhance the fluorescence (with EYFP) to facilitate tracking the
electroporated cells in our slice preparations. For electroporation, we
placed a 1 mm platinum Petri dish electrode (positive pole; Protech
International, San Antonio, TX) beneath the slice and injected 5 g of
DNA into the electroporation site using a micropipette (Narishige, Gre-
envale, NY). A 0.1mm finely etched needle platinum electrode (gift from
Edward Stern, Massachusetts General Hospital) was placed in the slice,
and three to five electrical pulses were delivered (each pulse 5 ms width,
100 Hz, and 50V; ElectroSquarePorator T830; BTX, Hawthorne, NY).
As in the case of the DiI labeling experiments, the site of electropora-
tion was200–400 m ventral to the pallial-striatal angle in the rostral
and caudal slices (Fig. 2A). Thus, in the rostral slices, the electroporated
cells originated in the lateral and medial ganglionic eminences, whereas
in the caudal slices, the electroporated cells
originated from the caudal ganglionic emi-
nence (Fig. 2A). The electroporated cells do not
express EYFP fluorescence for 12–24 h after
electroporation. By 24–48 h, the EYFP express-
ing electroporated cells are widely scattered
(Fig. 2B–F ). As a result, the site of electropora-
tion is not evident as a congregation of EYFP-
positive cells. Therefore, unlike the DiI deposi-
tion sites (Fig. 1C–E, white asterisks), the
electroporation sites are difficult to illustrate in
photomicrographs. To ascertain that the site of
electroporation was comparable with the site of
DiI deposition (Fig. 1A,B), we included fast
blue dye with the DNA constructs to verify our
DNA injection and needle electrode placement
sites in our preliminary experiments.
The D1 receptor agonist SKF 81297 (1 M;
concentration found to be effective in previous
slice preparation experiments) was added to the
culturemedium immediately after electropora-
tion, and the slices were maintained in culture
for 2 d. Control cultures did not receive any
additives. After the 2 d culture period, electro-
porated EYFP-labeled cells were observed in the
developing striatal fields (Fig. 2B–E), at the
level of the lateral (Fig. 2B,C),medial (Fig. 2D),
and caudal (Fig. 2E) ganglionic eminences as
well as in the cortex (Fig. 2F). We analyzed the
position and number of EYFP-labeled cells in
the slices, as described above for DiI-labeling
experiments.
GABA Immunohistochemistry. E15mice were
perfused with 2% acrolein in 0.1 M phosphate
buffer, pH 7.2, and the brains were fixed over-
night at 4°C in the same fixative, cryoprotected
in 30% sucrose, and sectioned at 50 m thick-
ness in the coronal plane on a sliding mic-
rotome. The sectionswere processed for immu-
nohistochemistry using antibodies to GABA (rabbit polyclonal, 1:3000;
Incstar, Stillwater, MN), biotinylated secondary antibody (Jackson Im-
munoResearch, West Grove, PA), avidin–biotin kit (Vector Laborato-
ries, Burlingame, CA), and nickel ammonium sulfate (0.02%; Sigma)
enhancement of diaminobenzidine reaction product as described previ-
ously (Crandall et al., 2004).
Calculation of GABA-positive cell numbers. GABA-positive cells were
counted by a single investigator blinded to experimental treatment
groups in 50-m-thick sections through the presumptive medial pre-
frontal cortex. The counts were performed using a 40 objective lens in
a sector that extended from the ventricular border to the pial surface of
the cerebral wall. The counts were expressed as number of cells per 300
m2. Subsequently, the number of GABA-positive cells was reanalyzed
separately for the different laminas of the cerebral wall: ventricular zone
(VZ)/subventricular zone (VZ), intermediate zone (IZ), subplate (SP)/
cortical plate (CP), and the marginal zone (MZ).
Cytoplasmic dynein heavy chain and TuJ1 immunocytochemistry in stri-
atal neurons exposed toD1 orD2 receptor agonists in culture.Dams carrying
E15 mice were anesthetized, as described above. The embryos were re-
moved and decapitated, and the brains were dissected in cold PBS. Basal
forebrain samples containing neostriatal differentiating fields as well as
the lateral, medial, and caudal ganglionic eminences were dissected from
the overlying cerebral wall, washed with sterile PBS, and incubated with
0.25% trypsin at 37°C for 20 min. The samples were washed with culture
medium, and the cells were gently dissociated using a sterile plastic pi-
pette, passed through a 40 m cell strainer, and resuspended in neuro-
basal medium (Invitrogen) containing 0.1 g/l penicillin/streptomycin
and supplemented with B27 (Invitrogen) 2 mM L-glutamine, and 10%
fetal bovine serum (Invitrogen). The cells were plated on 24-well poly-
D-lysine and laminin BD Biocoat tissue culture plates (BD Biosciences,
Figure 2. D1 receptor gain-of-function assay was performed by electroporating D1 receptor–EYFP constructs into the basal
forebrain of E15 mouse brain slices. A, The location of the electroporation sites (green asterisks) is shown in diagrams of repre-
sentative rostral and caudal slices. As in the DiI-labeling experiments (Fig. 1), the constructs were electroporated at the border
between the lateral and medial ganglionic eminences (LGE and MGE, respectively) in rostral slices and in the caudal ganglionic
eminence (CGE) in caudal slices. The electroporated cells scatter widely within 24 h, making it difficult to illustrate a prominent
EYFP-positive electroporation site. Green arrows in A indicate that EYFP-labeled cells migrate in multiple directions, including
toward the cerebral wall (CX). B–F, Examples of E15 mouse brain slices electroporated with the EYFP-labeled constructs and
maintained in vitro for 2 d. A fluorescence image (B) is superimposed on the bright-field image (C) to register position of labeled
cells with anatomical landmarks. Images inD–F are such superimposed images. Labeled cells are seen near the site of electropo-
ration in the lateral ganglionic eminence (LGE;B–D),medial ganglionic eminence (D), caudal ganglionic eminence (E), and in the
differentiating striatum (STR; white arrows in B and C; black arrows in D and E). Some electroporated, EGFP-positive cells have
migrated to the cortex over the 2 d period (black arrows in E). The shaded areas in A represent the lateral ventricles. V, Lateral
ventricle; HIP, hippocampus.
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Bedford, MA) at a density of 300,000 cells per
well. Cultures were maintained in a humidified
incubator at 37°C under 5% CO2. On day 3 in
vitro, cells were treated for 24 h with cytarabine
(10 M) to kill proliferating cells. On day 7 in
vitro, cells were treated for 24 hwithD1 receptor
agonist SKF 81297 (1 M) or D2 receptor ago-
nist quinpirole hydrochloride (20M). Control
cultures did not receive any additives. The cul-
tures were fixed with 4% paraformaldehyde in
0.1 M phosphate buffer for 15 min. Immunocy-
tochemistry was performed using rabbit anti-
cytoplasmic dynein heavy chain (CDHC) at
1:100 dilution (sc-9115; Santa Cruz Biotech-
nology, Santa Cruz, CA) or mouse anti--III
tubulin at 1:500 (TuJ1 cloneMAB5544; Chemi-
con, Temecula, CA) antibodies. Rabbit anti-
CDHC signal was detected with biotinylated
horse anti-rabbit at 1:500 (Jackson ImmunoRe-
search) and streptavidin–Alexa 546 at 1:500
(Invitrogen). -III tubulin was detected with
anti-mouse Alexa 488 at 1:500 (Invitrogen).
Nuclei were labeled with DAPI.
Results
Although genes encoding five dopamine
receptors have been cloned (Sibley and
Monsma, 1992), based on mechanisms of
action and availability of pharmacological
ligands (Stoof and Kebabian, 1984), two
major categories of dopamine receptors
are commonly recognized: D1 receptor
(D1 and D5; also called D1A and D1B, re-
spectively, in rodents) and D2 receptor
(D2, D3, and D4). When we refer to the D1
or D2 receptor in this study, we refer col-
lectively to the D1 and D5 subtypes or D2,
D3, and D4 subtypes, respectively. How-
ever, in the dopamine receptor knock-out
mice used in this study, genes encoding
either the D1 or the D2 subtype are deleted,
leaving genes for the other receptor sub-
types intact.
Dopamine D1 receptor activation
increases and D2 receptor activation
decreases basal forebrain to cerebral
wall neuronal migration
Weexamined the effects of D1 orD2 recep-
tor activation on neuronal migration from
the basal forebrain to the cerebral wall in
E15 mouse forebrain slice preparations.
We added D1 receptor agonist SKF 81297 (1 or 10 M) or D2
receptor agonist quinpirole (10 or 20M) to the culture medium
immediately after application of theDiI. Control cultures did not
contain any drugs. Our previous in vivo and in vitro studies
(Ohtani et al., 2003; Popolo et al., 2004; Araki et al., 2006) con-
firmed the specificity and selectivity of both the agonists at the
concentrations used here. Figure 1 shows examples ofDiI-labeled
slices fromcontrol (Fig. 1C),D1 agonist-treated (Fig. 1D), andD2
agonist-treated (Fig. 1E) experimental groups. Individual DiI-
labeled cells at higher magnification are shown in Figure 3A.
Initially, we analyzed the data separately for the rostral and
caudal slices to determinewhether the effects ofD1 orD2 receptor
activation on neuronalmigrationwere different on cells originat-
ing in the lateral/medial ganglionic eminences (rostral slices)
compared with the effects on cells derived from the caudal gan-
glionic eminence (caudal slices). The average percentage of DiI-
labeled cells entering the cerebral wall was not different between
the rostral and caudal slices after exposure to the D1 receptor
agonist SKF 81297 [rostral (n  5), 69.1  5.1; caudal (n  4),
65.6 8.9; t 0.37; p 0.7] or the D2 receptor agonist quinpi-
role [rostral (n 3), 33.9 0.8; caudal (n 4), 40.9 3.4; t
1.73; p  0.17]. Therefore, in the following description, we
present data combined from the rostral and caudal slices (i.e.,
from the lateral, medial, and caudal ganglionic eminences).
The D1 receptor agonist SKF 81297 (1 M) significantly in-
creased the percentage of DiI-labeled cells reaching the cerebral
wall [20%; control (n 16), 51.9 3.6; SKF 81297 (n 17),
Figure3. Morphology ofmigrating neurons.A,B, Cellswithmultiplemorphological characteristics ofmigrating neuronswere
found entering the cerebralwall after DiI labeling (A) or electroporation of D1 receptor–EYFP constructs (B) in E15 forebrain slices.
Examples are taken from different laminas of the cerebral wall of slices exposed to the D1 receptor agonist SKF 81297.
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62.7 3.5; t 2.18; p 0.04], whereas the D2 receptor agonist
quinpirole (20 M) significantly decreased it by 38% [quinpi-
role at 20 M (n 14), 32.4 3.5; control (n 16), 51.9 3.6;
t 4.01; p 0.01). Quinpirole did not produce significant effects
at 10 M concentration [quinpirole at 10 M (n  13), 58.02 
4.8; control (n 16), 51.9 3.6; t 0.274; p 0.27). SKF 81297
also did not produce significant effects at 10 M concentration
[SKF 81297 at 10 M (n  9), 56.54  2.7; control (n  16),
51.9  3.6; t  0.83; p  0.42). Therefore, we used 1 M SKF
81297 and 20 M quinpirole in of all our subsequent
experiments.
Variability in the size of the DiI deposit can introduce vari-
ability in the numbers of DiI-labeled cells entering the cerebral
wall. We took two measures to address the issue. First, as men-
tioned inMaterials andMethods, we calculated the percentage of
DiI-labeled cells that entered the cerebral wall as a percentage of
the total number of DiI-labeled cells in a given slice, in all of our
experiments. Therefore, any variability in the total number of
DiI-labeled cells could not have contributed to variability in the
relative numbers of DiI-labeled cells migrating to the cerebral
wall in the different slices. Second, we compared the average total
numbers of DiI-labeled cells in each slice in each of the experi-
mental groups. We found that the average total DiI-labeled cell
numbers were not significantly different among the different ex-
perimental groups [SKF 81297 (n  17), 233.5  47.7; control
(no drugs; n 16), 292.9 47.0; t 1.82; p 0.18; quinpirole
(n  14), 256.9  71.6 vs control, t  1.14, p  0.27]. Thus,
variability in the total numbers of cells labeled in a slice did not
produce artifacts in our data.
Next, we exposed the slices to the D1 receptor antagonist SCH
23390 [10 M; concentration shown to be effective previously
(Ohtani et al., 2003; Popolo et al., 2004; Araki et al., 2006)] for 2 h
and then added dopamine (10M; see below for determination of
effective concentration) to the medium in the presence of the
antagonist. In this paradigm SCH 23390 blocks the D1 receptors,
and dopamine can activate only D2 receptors. We found that the
percentage of DiI-labeled cells reaching the cerebral wall was sig-
nificantly decreased by 45% [SCH 23390 (n  6), 23.4  6.7;
control (n 16), 51.9 3.6; t 3.76; p 0.01], confirming that
blocking the D1 receptor and activating the D2 receptor decreases
the neuronal migration. We performed the complementary ex-
periment by adding the D2 receptor antagonist eticlopride [20
M; concentration shown to be effective in previous studies
(Ohtani et al., 2003; Popolo et al., 2004; Araki et al., 2006)] to the
medium first and dopamine (10M) 2 h later. In this experiment,
dopamine can activate only D1 receptors, and the percentage of
DiI-labeled cells reaching the cerebral wall increased significantly
by 18% [eticlopride (n  4), 68.8  7.1; control (n  16),
51.9  3.6; t  2.12; p  0.04]. Thus, blocking the D2 receptor
and activating the D1 receptor increased the migration.
Dopamine increases basal forebrain to cerebral wall
neuronal migration
Because dopamine is the naturally occurring ligand forD1 andD2
receptors, we examined whether dopamine per se influenced
neuronal migration. We added dopamine (1, 10, or 20 M) dis-
solved in the antioxidant ascorbic acid (0.01%) or ascorbic acid
alone to the medium and placed DiI in the ganglionic eminence.
Dopamine at the concentration used here activates its receptors
in vivo and in vitro (Ohtani et al., 2003; Popolo et al., 2004; Araki
et al., 2006). After a 48 h culture (change ofmediumand additives
after the first 24 h), dopamine (10 M) significantly increased by
15% the percentage of DiI-labeled cells reaching the cerebral
wall [dopamine plus ascorbic acid (n 17), 60.6 1.5; ascorbic
acid alone (n 7), 45.5 3.8; t 2.87; p 0.01]. Ascorbic acid
alone did not produce significant effects [ascorbic acid (n  7),
45.5 3.8; control (no additives; n 7), 51.9 3.6; t 0.95; p
0.34]. Dopamine did not produce significant effects at 1 or 20M
concentrations [1 M (n  15), 43.23  3.2; 20 M (n  8),
44.27  3.6; control (ascorbic acid; n  7), 45.5  3.8; 1 M vs
control, t 1.70, p 0.1; 20 M vs control, t 1.38, p 0.18].
The 1 M concentration may have been too low to activate the
receptors, whereas at 20 M, both D1 and D2 receptors may have
been activated, offsetting the effects of each other.
These data indicate that dopamine increases neuronal migra-
tion to the cerebral wall, an effect that is similar to the effects ofD1
receptor activation and opposite of D2 receptor activation. A
likely explanation for D1 receptor-like effects of dopamine is that
the density of D1 receptor binding sites is 10-fold higher than D2
receptor binding sites in the E15 mouse striatum (Ohtani et al.,
2003). Therefore, dopamine at the concentration used here (10
M) may activate the D1 receptors predominantly.
Gain of D1 receptor function increases neuronal migration
from the basal forebrain to the cerebral wall
We electroporated D1 receptor–EYFP (D1R–EYFP) or EYFP-
only constructs into cells of the basal forebrain in E15 slice prep-
arations. The electroporated cells expressed EYFP fluorescence,
were viable for at least 48 h in vitro, and were observed in the
striatal fields, ganglionic eminences, and the cerebral cortex (Fig.
2B–F). Because the culture medium does not contain dopamine
or any other D1 receptor ligand, we exposed the D1R–EYFP elec-
troporated slices to the D1 receptor agonist SKF 81297 (1 M).
Control slices also received D1 receptor–EYFP electroporation
but no pharmacological agents. There was a significant 30%
increase in the average percentage of D1R–EYFP electroporated
cells entering the cerebral wall in the slices exposed to SKF 81297
compared with control slices [control (n  4), 47.4  5.2; SKF
81297 (n  3), 67.3  4.2; t test  2.82; p  0.04]. These data
demonstrate that activation of the electroporated D1 receptor is
sufficient to augment neuronal migration.
Electroporation per se did not impair cell migration because
migration of the EYFP-labeled cells to the cerebral wall was com-
parable with migration of DiI-labeled cells (compare Figs. 1, 2).
In other words, the percentage of EYFP-labeled cells entering the
cerebral wall in the control slices (i.e., without SKF 81297) was
comparable with the percentage of labeled cells entering the ce-
rebral wall in our DiI labeling studies under control conditions
(i.e., no drugs added). Thus, the percentage of EYFP-labeled cells
in the control slices was 47.4  5.2; DiI-labeled cells in control
slices was 51.9  3.6 in our experiments using the D1 or D2
receptor agonists/antagonists and 52.5 1.2 in slices from wild-
type littermates of the dopamine receptor knock-out mice.
As in the case of the DiI-labeling experiments, we standard-
ized the size of the electroporation site to minimize the variation
in the number of EYFP-labeled cells per slice under the different
conditions. There was no statistically significant difference in the
total numbers of EYFP-labeled cells per slice [D1R-EYFP no
drugs, 219.8 32.6 (n 4); D1R-EYFP plus SKF 81297, 236.7
69.1 (n  3); t  0.24; p  0.82). As was the case with the
percentage of the EYFP-labeled cells entering the cerebral wall,
the total numbers of EYFP-labeled cells per slicewere comparable
with the corresponding numbers obtained in our DiI-labeling
experiments
We did not perform D2 receptor electroporation because we
were concerned that the effects of gain of D2 receptor function
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maybe less pronounced than that of theD1
receptor. In our studies with receptor ago-
nists, the magnitude of the effects of acti-
vation of the endogenous D2 receptor was
greater than that of the endogenous D1 re-
ceptor (38 vs 20%). Therefore, activation
of the electroporated D2 receptor might
not have decreased the migration further
(compared with the activation of the en-
dogenous receptors already present on the
cells),making theD2 receptor electropora-
tion potentially less informative than the
D1 receptor electroporation.
Dopamine receptor activation
influences migration of multiple
cell types
Migrating neurons display different morphologies, each believed
to correlate with specific stages or modes of migration (Nadara-
jah et al., 2002; Tabata and Nakajima, 2003; Bellion et al., 2005).
Different morphologies may also correlate with neuronal neu-
ropeptide content or functional subtype (Xu et al., 2004; Butt et
al., 2005). Because neuropeptide expression patterns of GABA
neurons are not fully established until postnatal stages (Xu et al.,
2004), we examined different morphological types of DiI- or
EYFP-labeled neurons in the cerebral wall. Cells with multiple
morphologies, from bipolar to multipolar, were present under
the different experimental conditions (Fig. 3). The laminar posi-
tion of the migrating cells coupled with orientation of the long
axis (horizontal or vertical) with respect to the ventricular surface
may reflect modes of migration (e.g., ventricle or pia directed)
(Nadarajah et al., 2001, 2002) or cell fate (progenitor or postmi-
totic) (Noctor et al., 2004). Our analysis did not reveal differences
with respect to orientation of the cell soma in the different lami-
nas of the cerebral wall: all orientations in all laminas were seen
under the different conditions (Fig. 3). Therefore, dopamine re-
ceptor activation did not produce selective effects on particular
cell types.
Dopamine receptor loss of function and basal forebrain to
cerebral wall neuronal migration
We analyzed neuronal migration in slice preparations fromwild-
type and D1 or D2 receptor knock-out mice (crosses between
heterozygous mice). We exposed the slices to dopamine (10 M)
plus ascorbic acid (0.01%) for 48 h. In the D1 receptor knock-out
mouse, dopamine can activate only D2 receptors [and D5 recep-
tors, which have low expression in the striatum (Vrana et al.,
1995; Jung and Bennett, 1996; Surmeier et al., 1996)], and, in the
D2 knock-out mouse, it can activate only D1 receptors [and D3,
D4, or D5 receptors, low in the striatum (Vrana et al., 1995; Jung
and Bennett, 1996; Surmeier et al., 1996)]. Because D1 receptor
activation increases and D2 receptor activation decreases migra-
tion, we predicted that the percentage of DiI-labeled cells enter-
ing the cerebral wall would be decreased in the D1 receptor
knock-out mice and increased in the D2 knock-out mice. This
was indeed the case.We found an51% decrease in the percent-
age of DiI-labeled cells entering the cerebral wall in theD1 knock-
out mice (26.7  2.8; n  8) compared with wild-type (52.3 
2.3; n 5) littermates (t 6.32; p 0.01). There was an23%
increase in neuronal migration in the D2 receptor knock-out
(68.2 2.6; n 5) compared with wild-type (52.5 1.2; n 6)
mice (t  5.82; p  0.001). These data confirm previous data
using D1 or D2 receptor agonist/antagonist that activation of the
D1 receptors increases and D2 receptors decreases basal forebrain
to cerebral wall neuronal migration. Figure 4 shows examples of
DiI-labeled slices from wild-type (Fig. 4A), D1 receptor knock-
out (Fig. 4B), and D2 receptor knock-out (Fig. 4C) mice.
As in the case of the experiments using the D1 andD2 receptor
agonists in the wild-type mice, we took two measures to address
potential variation in the numbers of DiI-labeled cells per slice
under the different conditions. First, we calculated the percentage
of DiI-labeled cells that entered the cerebral wall as a percentage
of the total number of DiI-labeled cells in a given slice. Therefore,
any variability in the total number of DiI-labeled cells could not
have contributed to variability in the relative numbers of DiI-
labeled cells migrating to the cerebral wall in the different geno-
types. Second, we compared the average total numbers of DiI-
labeled cells in each slice in each genotype. There was no
statistically significant difference in the total numbers of DiI-
labeled cells per slice between the different groups [wild type,
237.5 45 (n 5); D1 knock-out, 260.9 42.1 (n 8); t 0.37;
p 0.71; D2 knock-out, 299.8 89.7 (n 5); wild type, 281.0
20.0 (n 5); t 1.41; p 0.19].
Numerical density of GABA-positive cells in the cerebral wall
of dopamine receptor knock-out mice
Because themajority ofDiI-labeled neurons entering the cerebral
wall are GABA neurons (Nery et al., 2002; Xu et al., 2004; Butt et
al., 2005; Yozu et al., 2005) and because neuronal migration is
affected in the D1 and D2 receptor knock-out mice, we predicted
that the numbers of GABA-positive cells in the cerebral wall of
E15 D1 or D2 receptor knock-out mice would be altered. We
performed immunohistochemistry on sections of E15 wild-type
(WT), D1 receptor knock-out (D1/), and D2 receptor knock-
out (D2/) embryos to identify GABA-positive cells (Fig. 5)
and calculated numerical density of GABA-positive cells in the
presumptive medial prefrontal cortex (Table 1). We found a sig-
nificant25%decrease inGABA-positive cells in theD1 receptor
knock-outmice and a significant44% increase in the D2 recep-
tor knock-out mice (Table 1). Early (E12–E14) versus late (E15)
generated GABA neurons and GABA neurons derived from the
lateral, medial, and caudal ganglionic eminences may follow dif-
ferentmigration trajectories and arrive in different laminas of the
embryonic cerebral wall (Anderson et al., 2001; Ang et al., 2003).
The loss of D1 or D2 receptormay affect the different populations
differently. Therefore, we analyzed GABA-positive cells sepa-
rately in each lamina: VZ, SVZ, IZ, CP, SP, andMZ (Fig. 4, Table
1). The average GABA cell numerical density in theMZ or CP/SP
was not affected significantly in D1 or D2 receptor knock-out
mice (Table 1). However, in the IZ, GABA cell numerical density
Figure 4. A–C, Examples of slice preparations from wild-type (WT; A), D1 receptor knock-out (D1/; B) and D2 receptor
knock-out (D2/;C) E15mouse embryos showingDiI-labeled cells (white arrows) that havemigrated from thebasal forebrain
to the cerebral cortex (Cortex). The slices were exposed to dopamine (10M) plus ascorbic acid (0.01%) andmaintained for 2 d in
vitro. The DiI deposition site in the basal forebrain is visible (white asterisks). There are fewer DiI-labeled cells in the cortex of the
D1 receptor knock-out mouse and relatively greater numbers in the cortex of the D2 receptor knock-out mouse, indicating the
opposite effects of the loss of D1 or D2 receptor on neuronal migration.
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decreased by 48% in the D1 receptor knock-out mice and in-
creased by 96% in the D2 receptor knock-out mice (Table 1).
Similarly in the VZ/SVZ, the GABA cell numerical density signif-
icantly decreased by 53% in the D1 receptor knock-out mice
and significantly increased by143% in the D2 receptor knock-
outmice (Table 1). Thus, the overall effects of the loss of theD1 or
D2 receptor appear to be attributable to the significant changes in
the IZ and VZ/SVZ.
Dopamine receptor activation induces redistribution of
cytoplasmic dynein motor protein
Migrating neurons undergo cytoskeletal reorganization concur-
rent with process extension or nuclear translocation (Bellion et
al., 2005; Schaar and McConnell, 2005). A key mediator of the
cytoskeletal reorganization is themotor protein CDHC. Changes
in the intracellular distribution of CDHC are implicated in me-
diating neuronal migration (Morris et al., 1998; Morris, 2000).
CDHC localizes to centrosomes near the nucleus in mitotically
active neuroepithelial precursor cells and
distributes along the neurites in differenti-
ating or migrating neurons (Sasaki et al.,
2000; Wynshaw-Boris and Gambello,
2001; Shu et al., 2004). We examined
whether dopamine receptor activation al-
tered the distribution of CDHC in primary
neuronal cultures obtained from the gan-
glionic eminence/striatum of E15 mice.
Because CDHC associates with neuronal
class III -tubulin (TuJ1), we also exam-
ined the distribution of the TuJ1 and its
colocalization with CDHC. The cultures
were exposed to the D1 receptor agonist
SKF 81297 (1 M) or the D2 receptor ago-
nist quinpirole (20 M), and CDHC and
TuJ1 were labeled by immunocytochemis-
try. In control cultures, CDHC was local-
ized predominantly to the cell body (Fig.
6B; higher-magnification view in BA), and TuJ1 was principally
localized to the neurites (Fig. 6C). In cultures exposed to the D1
receptor agonist SKF 81297, CDHC localized to the soma, with
extensions into the proximal segments of the neurites near the
soma (Fig. 6F; higher magnification in FA). In these cultures,
TuJ1 labeling was more intense than in controls, although it re-
mained localized to the neurites (Fig. 6G), as in control cultures.
CDHC and TuJ1 colocalization produced a prominent tuft-like
pattern extending into the proximal segments of the neurites
(Fig. 6H, arrows). In cultures exposed to the D2 receptor agonist
quinpirole, the labeling pattern was strikingly different: the
CDHC labeling was virtually exclusively localized to the cell body
and did not extend into the neurites (Fig. 6 J; higher magnifica-
tion in JA). TuJ1 localized to neurites (Fig. 6K), as in control
cultures (Fig. 6C), but unlike in SKF 81297-exposed cultures, it
was not localized to the cytoplasm. CDHC–TuJ1 colocalization
(Fig. 6L) did not reveal tuft-like localization that was seen in the
SKF 81297-exposed cultures. Thus, D1 receptor activation in-
creased TuJ1 labeling intensity andmobilizedCDHCandTuJ1 to
produce a tuft-like pattern extending into the proximal segments
of the neurites, whereas D2 receptor activation produced a con-
densation of the labeling around the nucleus (Fig. 6M).
Discussion
Our data show that dopamine receptor activation can modulate
neuronal migration from the basal forebrain to the cerebral wall.
The effects were similar at rostral and caudal levels of the basal
forebrain, suggesting comparable effects onmigration of neurons
originating in the medial and caudal ganglionic eminences. D1
receptor activation promoted themigration, whereasD2 receptor
activation decreased it. We confirmed these findings by gain-of-
function assay, in which D1 receptor was electroporated into stri-
atal cells in vitro and activated with a pharmacological agonist.
We also performed loss-of-function assays in which slice prepa-
rations from D1 or D2 receptor knock-out mice were used. Anal-
ysis of GABA neuron numbers in the cerebral wall of the dopa-
mine receptor knock-outmice confirmed the effects of dopamine
receptor activation on GABA neuron migration.
A hallmark of the effects of dopamine in the mature brain is
the opposing actions of D1 and D2 receptors on a variety of func-
tions (Stoof and Kebabian, 1984). This dichotomy is evident in
the effects of dopamine on cell proliferation in the embryonic
telencephalon (Ohtani et al., 2003; Popolo et al., 2004) and, as
shown here, also in the effects of dopamine on GABA neuron
Figure5. GABA-positive cells in the cerebralwall of E15mouse embryos.A–C, GABA immunohistochemistrywas performed in
coronal sections through themedial prefrontal cortex of littermate E15wild type (WT;A); D1 receptor knock-out (D1/;B) and
D2 receptor knock-out (D2/; C) mice. GABA-positive cells (black arrows) are distributed in all laminas of the cerebral wall.
Overall, thereare fewerGABA-positiveprofiles in theD1
/ cerebralwall (B) andgreaternumbers in theD2
/ cerebralwall (C)
compared with the wild type (A). GABA labeling shows variability among the different laminas and across genotypes (especially
SP). Quantitative comparisons (see Table 1) showed significant differences among the three genotypes in the IZ, VZ, and SVZ.
Table 1. GABA-positive cell numerical density in the E15 presumptivemedial
prefrontal cortex
Experimental group Mean SEM t value* p value
Entire cerebral wall (all laminas)
WT 86.9 5.9
D1-KO 64.8 2.1 3.51 0.013
D2-KO 123.5 1.9 5.87 0.001
Marginal zone
WT 34.6 2.4
D1-KO 31.4 0.8 1.26 0.25 (NS)
D2-KO 37.4 2.4 0.86 0.43 (NS)
Cortical plate subplate
WT 22.8 2.4
D1-KO 18.2 3.0 1.18 0.28 (NS)
D2-KO 33.9 6.8 1.62 0.16 (NS)
Intermediate zone
WT 26.5 3.0
D1-KO 13.8 1.3 3.83 0.009
D2-KO 51.9 3.3 5.68 0.001
Ventricular zone subventricular zone
WT 3.0 0.6
D1-KO 1.4 0.3 2.44 0.02
D2-KO 7.3 0.9 4.04 0.007
We calculated GABA-positive cell numbers in the entire cerebral wall as well as in each lamina between wild-type
(WT), D1 receptor knock-out (D1-KO), and D2 receptor knock-out (D2-KO) embryos and compared the data between
groups using a t test. GABA-positive cell numerical density in the E15 presumptive medial prefrontal cortex. *, All
comparisons are to the wild-type group; n 4 embryos for each experimental group. NS, Not statistically signifi-
cant, i.e., p 0.05.
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migration. Thus, a physiological balance
between D1 and D2 receptor expression
and activation appears to be important for
normal brain development. We do not
know whether some neurons in the em-
bryonic striatum express exclusivelyD1 re-
ceptors and others exclusively D2 recep-
tors. It is likely that all neurons in the
embryonic striatum express both D1 and
D2 receptors but some are enriched in D1
and others in D2 receptors, as in the ma-
ture striatum (Gerfen, 1992; Surmeier et
al., 1996; Aizman et al., 2000). It is tempt-
ing to speculate that neurons enriched in
D1 receptorsmay bemore likely tomigrate
away from the embryonic basal forebrain,
whereas those enriched in D2 receptors
may remain within it, offering a basis for
specification of dorsal versus ventral fates
for cells produced in the basal forebrain.
Our data raise the possibility that dopa-
mine imbalance could underlie GABA
dysfunction in developmental disorders
such as schizophrenia, autism, or atten-
tion deficit because some degree of dys-
function in both dopamine andGABA sys-
tems is involved in these disorders (Benes,
2000; Robinson et al., 2001; Treiman,
2001; Casanova et al., 2003; Levitt et al.,
2004). Fetal cocaine exposure also results
in impairment of dopamine and GABA
systems (Wang et al., 1995; Friedman et al.,
1996; Crandall et al., 2004; Stanwood and
Levitt, 2007). Thus, dopamine imbalance,
GABA dysfunction, and developmental
onset appear to be common factors in
these conditions. Our data offer a novel
perspective on the pathophysiology of
these conditions by suggesting dopamine imbalance as a cause of
impaired migration of GABA neurons. Another novel insight
offered by our data is that dopamine imbalance can alter GABA
neuron development in brain regions thatmay not be enriched in
dopamine or its receptors. Specifically, during the period E12–
E15 when GABA neuron migration from the basal forebrain to
the cerebral wall is robust inmice, dopaminergic innervation and
dopamine receptor expression are high in the basal forebrain and
low in the cerebral wall (Ohtani et al., 2003; Popolo et al., 2004).
However, our data show that imbalance in dopamine receptor
activation occurring even earlier than E15 can alter cortical
GABA neuron development. These observations underscore the
significant role dopamine receptor activation in the embryonic
basal forebrain can play for the development of GABA circuits
throughout the forebrain, even in regions that may not be en-
riched in dopamine during development or at maturity.
We do not know whether the changes in cortical GABA cell
numbers produced by imbalance in dopamine receptor function,
such as those in the E15 D1 or D2 receptor knock-out mice, are
permanent. However, recent evidence suggests that even a delay
in the arrival of the GABA neurons in the cerebral wall, such as
that which occurs in the D2 receptor knock-out mouse, can in-
terfere with the normal development of cortical circuitry (Ben-
Ari et al., 2004). Therefore, even a transient impairment of cor-
tical GABA neuron development in the embryonic period can
lead to lasting changes in cortical function, emphasizing the rel-
evance of our data to an entire class of neuropsychiatric condi-
tions characterized by developmental onset and dysfunction in
both dopamine and GABA systems.
Previous studies had demonstrated a role for dopamine in cell
proliferation and differentiation in the embryonic striatum and
cerebral cortex (Zhang and Lidow, 2002; Ohtani et al., 2003;
Popolo et al., 2004; Zhang et al., 2005). We were concerned that
the changes in migration of DiI-labeled neurons produced by D1
and D2 receptor activation or by dopamine may be “secondary”
to changes in cell proliferation produced by dopamine receptor
activation (Ohtani et al., 2003; Popolo et al., 2004). In other
words, the increase in the percentage of DiI-labeled cells reaching
the cerebral wall after exposure of the slices to the D1 receptor
agonist or dopamine may be attributable to a larger number of
cells leaving the progenitor pool and becoming postmitotic in the
ganglionic eminence as a result of D1 receptor activation (Ohtani
et al., 2003; Popolo et al., 2004). The decrease inmigrationmay be
attributable to fewer cells becoming postmitotic as a result of D2
receptor activation. Thus, we could havemistaken changes in cell
output for changes in cell migration. Two lines of evidence argue
against those concerns. First, we expressed the number of DiI-
labeled cells reaching the cerebral wall as a percentage of the total
number of DiI-labeled cells in the entire slice. Therefore, our data
were “corrected” for any changes in the total number of cells in
Figure 6. Dopamine receptor activation and neuronal cytoskeleton. Striatal neurons from E15mice were grown in culture for
5 d and exposed to theD1 receptor agonist SKF 81297or theD2 receptor agonist quinpirole. Immunocytochemistrywas performed
to analyze distribution of the motor protein CDHC or the cytoskeletal protein neuronal -III tubulin (TuJ1). A, E, I, Nuclei were
labeled with the DNA stain DAPI. B, C, In control cultures (B), CDHC was distributed throughout the cell body and the neurites
(higher-magnification view in BA), and TuJ1 was principally localized to the neurites (C). D, Merged image of CDHC and TuJ1
labeling revealed overlap between the two proteins mainly in the neurites. F, In cultures exposed to SKF 81297, CDHC was
distributedmainly to the soma, with prominent extensions into the proximal segments of the neurites near the cell soma (higher
magnification in FA). G, In these cultures, TuJ1 was distributed to the neurites, as in control cultures. However, TuJ1 labeling was
more intense in the neurites in the SKF 81297-exposed cultures compared with controls (C vs G). H, Merged images of the SKF
81297-exposed cultures revealed prominent tuft-like colocalization of CDHC and TuJ1, near the nucleus and extending into the
proximal segments of the neurites (arrows in H ). J, In cultures exposed to quinpirole, CDHC labeling was condensed around the
nucleus (high-power view in JA). K, TuJ1 was distributed to neurites, as in control cultures (C), but, unlike in SKF 81297-exposed
cultures, it was not localized to the cytoplasm. L, Merged images of CDHC and TuJ1 labeling did not reveal the prominent tuft-like
colocalization.M, In summary, D1 receptor activation mobilizes CDHC and TuJ1 to produce a tuft-like pattern extending into the
proximal segments of the neurites, whereas D2 receptor activation produces a condensation of the labeling around the nucleus.
Scale bars: 15m.
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the ganglionic region. Second, cells that migrate from the gangli-
onic eminence to the cerebral wall predominantly originate in the
medial ganglionic eminence (Lavdas et al., 1999; Wichterle et al.,
2001; Nery et al., 2002). The effects of dopamine on cell prolifer-
ation are evident in the basal forebrain principally in the lateral
ganglionic eminence (Ohtani et al., 2003; Popolo et al., 2004).
Finally, in our electroporation studies, many of the electropo-
rated cells were in striatal differentiating fields, suggesting that
they were postmitotic. Activation of the electroporated D1 recep-
tor promoted migration of these cells. Thus, our data reveal a
novel dimension for the effects of dopamine in the developing
brain by demonstrating its role in GABA neuron migration, in
addition to its role in proliferation of neuroepithelial cells in the
telencephalon.
How dopamine can modulate neuronal migration is not
known. Regardless of specific mechanisms involved, cytoskeletal
reorganization is a prerequisite for neuronal migration or differ-
entiation. Therefore, we sought a link between dopamine recep-
tor activation and cytoskeletal changes in cultured striatal neu-
rons. We show that the effects of dopamine receptor activation
on neuronal migration are consistent with changes in neuronal
cytoskeleton. Dopamine receptor activation induces redistribu-
tion of CDHCwithin cultured striatal neurons. CDHC is amotor
protein implicated in movement of organelles during nuclear
translocation (Sasaki et al., 2000). Activation of D1 or D2 recep-
tors produces opposite effects on intracellular distribution of
CDHC consistent with the opposite effects of these two receptors
on neuronal migration. Activation of the D1 receptor-induced
redistribution of CDHC and -III tubulin to neurites, whereas
activation of the D2 receptor resulted in a prominent perinuclear
localization of CDHC and-III tubulin. The patterns of localiza-
tion of CDHC and -III tubulin in response to D1 receptor acti-
vation are consistent with migrating or differentiating neurons,
whereas the patterns in response toD2 receptor activation resem-
ble undifferentiated or mitotically active cells (Sasaki et al., 2000;
Wynshaw-Boris and Gambello, 2001; Shu et al., 2004). Thus, the
effects of dopamine receptor activation on neuronal migration
appear to have a basis at the level of the neuronal cytoskeleton.
We recognize that the data on dopamine receptor-induced cy-
toskeletal changes are from differentiating neurons maintained
in culture and not from migrating neurons per se. However, the
conclusions from these experiments likely have a bearing on do-
pamine receptor-induced cytoskeletal changes associated with
neuronal migration, especially because of the opposite effects of
D1 and D2 receptor activation on the cytoskeleton as well as neu-
ronal migration.
In conclusion, our data show that altering the physiological
balance between dopamine D1 and D2 receptor activation can
alter GABA neuron migration to the cerebral cortex in the em-
bryonic brain. Because the embryonic basal forebrain is enriched
in dopamine and its receptors and because the basal forebrain is
the source of GABA neurons of multiple forebrain regions in-
cluding the neocortex, hippocampus, striatum, nucleus accum-
bens, amygdala, and olfactory bulb (Parnavelas, 2000; Marin and
Rubenstein, 2001), dopamine imbalance in the embryonic brain
can impact GABA neuron development in multiple brain re-
gions. Subtle but significant GABA dysfunction in multiple tel-
encephalic regions is associated with a class of neurofunctional
disorders exemplified by schizophrenia, attention deficit, or au-
tism. Therefore, the intimate relationship between dopamine and
GABA neuron development revealed here may be critical for
gaining novel insights into the pathobiology of developmental
neurofunctional disorders or fetal cocaine exposure, all of which
involve dopamine and GABA neuron dysfunction.
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